Identification of Circulating Endocan-1 and Ether Phospholipids as Biomarkers for Complications in Thalassemia Patients

Identification of Circulating Endocan-1 and Ether Phospholipids as Biomarkers for Complications in Thalassemia Patients

Despite advances in our knowledge and attempts to improve therapies, β-thalassemia remains a prevalent disorder with increased risk for the development of cardiomyopathy. Using an untargeted discovery-based lipidomic workflow, we uncovered that transfusion-dependent thalassemia (TDT) patients had a...

Full description

Bibliographic Details
Main Authors: Amy Botta, Anik Forest, Caroline Daneault, Kostas Pantopoulos, Adisak Tantiworawit, Arintaya Phrommintikul, Siriporn Chattipakorn, Nipon Chattipakorn, Christine Des Rosiers, Gary Sweeney
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Metabolites
Subjects:
lipidomic
biomarker
diagnostic
therapeutic
thalassemia
Online Access:https://www.mdpi.com/2218-1989/11/2/70

Internet

https://www.mdpi.com/2218-1989/11/2/70

Similar Items